First National Advisers’s Boston Scientific BSX Stock Holding History

First National Advisers’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$282K	Buy	+6,608	New	+$359K	0.04%	231

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

First National Advisers's BSX Position: Q2 2026 in Review

First National Advisers opened a new position in Boston Scientific (BSX) in Q2 2026: 6,608 shares worth $282K. The stake represents 0.04% of the portfolio and ranks #231 among its holdings.

1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

First National Advisers held 6,608 shares of Boston Scientific worth $282K as of Q2 2026.
Boston Scientific was a new First National Advisers position in Q2 2026.
Boston Scientific made up 0.04% of First National Advisers's portfolio in Q2 2026, its #231 holding.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on First National Advisers's 13F filing for Q2 2026, filed 21 Jul 2026.